Metallomics (DOI): https://doi.org/10.1093/mtomcs/mfaf034
What the study examined
Colorectal cancer (CRC) is one of the most common malignancies worldwide, and its tumor microenvironment (TME) is shaped not only by cells and signaling molecules but by the local distribution of trace metals. Essential transition metals such as copper and iron are cofactors for enzymes that drive proliferation, angiogenesis, redox balance, and immune signaling, yet conventional bulk assays average metal content across an entire specimen and lose the spatial context that determines where metal-dependent biology actually occurs.
Srivastava and colleagues, working across Dartmouth's Geisel School of Medicine, Weill Cornell Medicine, and the Biomedical National Elemental Imaging Resource (BNEIR), set out to test whether elemental maps and gene-expression maps could be brought into a shared coordinate system so that metal accumulation could be interpreted alongside the transcriptional programs of the surrounding tissue. The work is explicitly framed as proof-of-concept: it analyzes a single, well-characterized CRC specimen from a patient with a left-colon, microsatellite-stable tumor (pathologic T3, node-positive, with liver metastasis) to demonstrate that a metals-based spatial pathway analysis is feasible and biologically informative before scaling to larger cohorts.
Methods: pairing elemental imaging with spatial transcriptomics
Serial sections of a single formalin-fixed, paraffin-embedded (FFPE) tumor block were split across complementary platforms. Metal distributions were imaged by laser-ablation inductively coupled plasma time-of-flight mass spectrometry (LA-ICP-TOF-MS) at roughly 5-micron resolution, capturing copper, iron, zinc, manganese, magnesium, potassium, and calcium simultaneously across the tissue. An adjacent section was profiled with the 10x Genomics Visium (CytAssist) spatial transcriptomics assay, which measures expression of on the order of 18,000 genes within 55-micron spots laid out across the same tissue architecture.
The central technical contribution is co-registration: the team developed a workflow (referred to as TRACE, Tissue Region Analysis through Co-registration of Elemental maps) to warp the elemental images and transcriptomic spots into alignment, so that a metal value and a gene-expression profile could be read out at the same physical location. Downstream analysis combined cell-type deconvolution (Cell2Location), spatial hotspot detection (Getis-Ord Gi*), factor analysis (MEFISTO), and predictive modeling (MISTy) to relate metal abundance to genes, inferred cell types, and histological structures. Predictive models reconstructed several metals from transcriptomic and cellular features with high fidelity (reported R-squared above ~75% for potassium, copper, manganese, magnesium, calcium, and iron), supporting the idea that these metal distributions are coupled to identifiable molecular programs rather than random.
Key findings: copper with immunity, iron with EMT
Copper accumulated in regions of active tumor growth and co-localized with increased expression of immune-response genes. The elevated-copper zones were enriched for interferon-gamma response signaling (reported p = 1.09e-12) and IL-6/JAK/STAT3 signaling, and copper abundance tracked with inferred dendritic cells, endothelial cells, and macrophage populations. This positions copper not simply as a proliferation cofactor but as a marker of immunologically active tumor territory.
Iron told a different spatial story. Elevated iron correlated with mesenchymal phenotypes concentrated at the tumor's proliferative, invasive front and with genes for epithelial-to-mesenchymal transition (EMT) and extracellular-matrix (ECM) remodeling. The EMT program was strongly enriched in iron-high regions (reported p = 4.38e-21), with individual correlations to fibronectin (FN1) and matrix metalloproteinase-9 (MMP9). Because EMT and ECM remodeling are hallmarks of local invasion and metastatic dissemination, iron's spatial signature aligns with the biology of a tumor edge preparing to spread.
Mechanistic interpretation
The two metal signatures map onto two distinct, biologically coherent compartments of the tumor. Copper is a required cofactor for enzymes in mitochondrial respiration, angiogenesis, and redox signaling, and 'cuproplasticity' has emerged as a theme in cancer where copper availability tunes proliferative and inflammatory signaling. Finding copper concentrated where interferon-gamma and IL-6/JAK/STAT3 programs are active is consistent with copper-dependent modulation of immune and stromal signaling in zones of active growth.
Iron participates in Fenton chemistry, oxygen sensing, and numerous metalloenzymes, and labile iron can promote the oxidative and signaling conditions that favor EMT. Its enrichment at the mesenchymal, matrix-remodeling front dovetails with a large literature linking iron dysregulation to invasion and metastasis. Importantly, the study is correlative and single-case: it establishes spatial co-occurrence and predictive coupling between metals and pathways, not causation. The authors present it as a template for hypothesis generation and for designing metal-targeted therapeutic and biomarker studies in larger CRC cohorts.
Relevance to the metal-microbiome-disease axis
This study sits at the metal-and-disease end of the metal-microbiome-disease axis: it shows, with spatial precision, that where metals accumulate inside a colorectal tumor predicts which disease-driving programs are switched on. That is the mechanistic payoff the axis points to, metal distribution shaping immune and invasive biology in situ.
The colon is also where host, diet, metals, and microbiota meet most directly. Dietary and environmental metal exposure, luminal iron in particular, is a well-studied modifier of the gut microbiome, and microbial competition for iron and other transition metals (nutritional immunity, siderophores, and metallophores) shapes which taxa thrive at the mucosal surface. A dysbiotic, metal-stressed microbiome is in turn linked to colorectal carcinogenesis. This paper does not measure the microbiome, so any microbiome connection is contextual rather than demonstrated here; its contribution is to sharpen the tumor-side half of the axis by resolving copper-immune and iron-EMT geography at micron scale. Spatial metallomics is a promising bridge for future work that would layer microbial spatial data onto the same elemental maps.
Key findings
- A 2025 Metallomics proof-of-concept study co-registered LA-ICP-TOF-MS elemental imaging (~5 um) with 10x Visium spatial transcriptomics in a single colorectal tumor using a workflow the authors call TRACE.
- Copper accumulated in zones of active tumor growth and correlated with immune-response gene expression, including interferon-gamma response (p = 1.09e-12) and IL-6/JAK/STAT3 signaling, and with dendritic cells, macrophages, and endothelial cells.
- Iron accumulated at the tumor's proliferative front and correlated with epithelial-to-mesenchymal transition (EMT, p = 4.38e-21) and extracellular-matrix remodeling, including FN1 and MMP9.
- Predictive models (MISTy) reconstructed copper, iron, manganese, magnesium, calcium, and potassium distributions from transcriptomic/cellular features with R-squared above ~75%, indicating tight coupling between metal geography and molecular programs.
- The work is correlative and based on one specimen; it is designed as a template and hypothesis-generator for larger CRC cohorts and metal-targeted biomarker/therapy studies, not as proof of causation.
Frequently asked questions
What is spatial metallomics?
Spatial metallomics maps where metals are located within a tissue, rather than measuring only their total amount. In this study, laser-ablation ICP time-of-flight mass spectrometry (LA-ICP-TOF-MS) imaged copper, iron, zinc, manganese and other elements at ~5-micron resolution, and those metal maps were co-registered with spatial gene-expression data so metal accumulation could be read alongside the surrounding molecular biology.
What did the study find about copper and iron in colorectal cancer?
Copper concentrated in regions of active tumor growth and correlated with immune-response gene programs (interferon-gamma and IL-6/JAK/STAT3 signaling). Iron concentrated at the tumor's invasive, proliferative front and correlated with epithelial-to-mesenchymal transition (EMT) and extracellular-matrix remodeling genes such as FN1 and MMP9.
Does this prove that metals cause colorectal cancer progression?
No. The study is a single-specimen, proof-of-concept analysis showing spatial correlation and predictive coupling between metals and disease pathways. It establishes feasibility and generates hypotheses; demonstrating causation would require larger cohorts and functional experiments.
How does this connect to the metal-microbiome-disease axis?
It strengthens the tumor-side link between metals and disease by showing that intratumoral metal distribution predicts immune and invasive gene programs. The colon is also where dietary and environmental metals interact with the gut microbiome, though this study measured tumor tissue rather than microbiota, so the microbiome connection here is contextual rather than directly demonstrated.